ARCHIVES

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief : Patricia LoRusso Named Associate Director Of Innovative Medicine at Yale Cancer Center

June 20, 2014

Clinical Trials Approved By NCI Last Month Are Listed

February 28, 2003

NCI Advisory Group, Other Cancer Meetings

August 30, 1991

NCI Staff Will Recommend That Comprehensive Recognition Be Withdrawn From Colorado Center

October 31, 1980

Impath Buys Clinical Studies Support Services Network.

September 28, 2001

Surprise Finding On HRT Stops Large Trial, Women Advised To Reconsider Long-Term Use Due to Increased Breast Cancer Risk

July 12, 2002